Downloadable Slides

Share

Program Content

Activities

  • 1L in HER2+ mBC
    First-line Therapy Selection in HER2+ mBC: Clinical/Nonclinical Factors and New Data
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 13, 2025

    Expires: November 12, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC. in partnership with Smart Patients.

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Partners

Smart Patients

ProCE Banner